💬 Think health insurance stocks are dead? Wall Street hates them right now — but that’s exactly when the biggest contrarian rotations start. Is this the most hated opportunity of 2026? The Industry Everyone Is Bashing Is Brewing a Major Rotation Mention “health insurance stocks” at a Wall Street cocktail party lately, and you’ll probably get a room full of eye-rolls. Nobody wants to touch this “unlucky” sector right now. $UnitedHealth(UNH)$ has crashed 50% from its highs, and sentiment across the industry is colder than an emergency room hallway. Over the past two years, headwinds have fallen like dominoes: unpredictable political winds, sudden surges in medical costs, and endless uncertainty. Investors have fled to AI or safe-haven assets, leaving

💬 Ever seen two blue-chip Canadian giants get thrown out with the trash? CNR and Telus are both getting crushed — but is the market overreacting? This might be one of the best contrarian setups of the year. When a stock drops 25%, the market starts calling it a “value trap.” When another stock plunges nearly 10% in one day on dividend panic, people hit sell. That’s exactly what’s happening to Canadian National Railway (CNR) and Telus (T). The real question: Is the market being too hasty — prematurely writing off two infrastructure giants? 1. The Written-Off Railway: $Core Natural Resources, Inc.(CNR)$ ’s Short-Term Pain, Long-Term Moat CNR’s share price has fallen roughly 25% since March 2024. The surface story is clear: freight volumes have weaken

Is the deep-sea mining game about to get a new Canadian disruptor? While TMC has ruled the spotlight for years, a tiny TSX venture is stepping in with a light-asset model to challenge the giant. Can SEAS outmaneuver the first mover — without building a single ship? In the deep-sea mining space, long dominated by The Metals Company (TMC), a newly rebranded Canadian-listed firm is pushing into the spotlight with a sharply different strategy. Recently, $DEEP SEA MINERALS CORP(CUHRF)$, formerly Copperhead Resources, revealed detailed plans to enter the Clarion-Clipperton Zone (CCZ) and the Cook Islands Exclusive Economic Zone (EEZ). The company has formally filed an exploration application with the U.S. National Oceanic and Atmospheric Administration

Looking for defensive growth in a crashing tech market? While most tech stocks are selling off hard, two Canadian under-the-radar winners are holding strong — and even surging. Let’s take a look at the resilient names that are outperforming when it matters most. While Canada’s stock market has held up relatively well in early 2026, supported by energy, materials, and major bank stocks on the Toronto Stock Exchange (TSX), the tech sector has become a heavy drag on the broader market. Amid widespread risk aversion and sharp pullbacks in many high‑flying tech names, two specialized Canadian technology companies have shown remarkable resilience. Instead of following the market downward, they have delivered independent, high‑return performance. $Firan Tec

💬 Global central banks are rushing home with gold, dumping USD reserves, and rebuilding financial sovereignty. Is this the biggest quiet revolution in monetary history? Let’s break it down. $Gold - main 2606(GCmain)$ A silent financial de-Westernization is accelerating across global central banks. France has just repatriated all its gold held in the United States. Poland’s central bank has been the world’s largest gold buyer for two years running. And China is selling U.S. Treasuries while adding gold for 16 straight months. These moves go far beyond traditional asset allocation. Gold is evolving from a commodity reserve into what nations now view as national security infrastructure. In April 2026, the Bank of France confirmed that all French

Who’s winning the oral weight-loss drug race? The GLP-1 weight-loss market is shifting from injectables to oral pills — and it’s still Novo vs. Lilly at the top. Which giant has stronger long-term momentum? Let’s break it down clearly. The weight-loss drug race is moving from the injectable first half to the oral second half. Late last year, the first oral GLP-1 weight-loss drug was approved, and analysts project the market will near $100 billion by 2030. At the table are the same two giants: Denmark’s Novo Nordisk (NVO) and U.S. star Eli Lilly (LLY). In the injectable era, Lilly overtook the market with superior efficacy from tirzepatide (Mounjaro/Zepbound) and aggressive production expansion, capturing 60% of the U.S. market. Now the battlefield has shifted to oral drugs. Can Novo Nordis

Tired of researching and picking single stocks? These 3 metal ETFs offer a simple, diversified way to invest in the critical raw materials powering infrastructure, manufacturing, and new energy technologies — without the risk of individual companies. Metal ETFs are investment tools that hold shares of mining & metals companies or track metal futures contracts. Metals are the foundational raw materials for infrastructure, manufacturing, and many emerging clean-energy technologies. That’s why demand for metals — from copper and iron ore to lithium and rare earths — tends to grow cyclically over time. For investors who want broad exposure to the metals sector without picking individual stocks, metal ETFs offer a simple solution. These funds typically invest in mining firms, metals produce